Two Bites, Taken Together: Parallel and Serial IPR Petitions

17 August 2015 IP Litigation Current Blog

As the body of institution and final decisions in inter partes review (IPR) trials grows, useful trends at both decision stages can be identified. One emerging trend is the relative likelihood that two petitions attacking one or more of the same claims will be more likely granted if filed in parallel (multiple petitions, simultaneously, on the same patent) as compared to when filed serially (multiple petitions, consecutively, on the same patent).

While the decision on whether to institute a trial is always up to the Board’s discretion under 35 U.S.C. § 314(a) (see, e.g., IPR2013-00324, Paper 19, at 4 (PTAB Nov. 21, 2013)), serial petitions where the same or substantially the same prior art or arguments have already been presented to the office face an additional statutory hurdle under 35 U.S.C. § 325(d) (which provides the PTAB with discretion to reject a petition where “the same or substantially” the same prior art is at issue in a separate proceeding before the Patent Office). The Board often uses § 325(d) to block the use of serial “follow on” petitions, preventing a petitioner from using a previous denial of institution as a roadmap for a “second bite at the apple.”

An analysis of parallel petitions attacking one or more of the same claims reveals that 57% of the time both parallel petitions were granted (as compared to 43% of the time where only a single parallel petition was granted).  Meanwhile, an analysis of serial petitions demonstrates that at least one serial petition was denied 56% of the time (serial petitions were only both granted 44% of the time).

A possible explanation for the greater likelihood of success on parallel petitions is the discretion afforded the Board under § 325(d) to reject petitions where the same, or substantially the same, prior art or arguments have already been presented. Therefore, the danger of filing serial petitions is that the later-filed petition might invoke the Board’s discretion as to what constitutes “substantially” the same art or argument in the earlier petitions. Although nothing prevents the Board from exercising its discretion under § 325(d) on parallel petitions, the Board does not invoke § 325(d) as often in those situations.

The danger of § 325(d) is enhanced by the lack of predictability as to what constitutes the same or similar art or argument across serial petitions. For example, in support of its denial of a later-filed petition after granting an earlier one, the Board criticized the petitioner for relying simply on different prior art references in its serial petition, stating:

Trial was instituted in the ’506 Proceeding on February 13, 2013. That proceeding involves the same patent, as well as the same claims, for which Petitioner is requesting inter partes review in the instant Proceeding. While Petitioner argues that the grounds are not redundant to those instituted on in the ’506 Proceeding, Petitioner does not provide any specific reasoning to support that argument, other than to state that the grounds are based on different prior art references.

IPR2014-00487, Paper 8, at 6 (PTAB Sept. 11, 2014). In contrast, in support of its grant of a later-filed petition, the Board notes the new combinations of art, stating:

We are not persuaded that the art and arguments presented in this Petition are the same or substantially the same prior art or arguments previously presented to the Office. For example, none of the grounds of unpatentability in this Petition rely upon exactly the same combination of prior art as the grounds of unpatentability asserted against the same claims in the 227 IPR. For example, the Petition relies upon a combination of Hitachi and Ohtsuka for disclosing algorithmically processing an image data set to a reduced image data set as claimed, while in contrast the petitions in the 227 IPR relied upon Hitachi alone.

IPR2014-01206, Paper 10, at 11 (PTAB Dec. 23, 2014). Thus, in one instance a petitioner’s mere new combination of art is given by the Board as a reason to deny the petition under § 325(d); in another instance, a new combination of art is given by the Board as a reason to grant the later-filed petition.

The Board decisions provide some guidance to petitioners seeking to avoid a § 325(d) denial.  For example, petitioners may want to avoid characterizing serial petitions as correcting deficiencies in a previous filing. Doing so tees up the Board’s “second bite of the apple” and “harassment” rationales as reasons to exercise its discretion and deny the petition. See, e.g., IPR2014-00581, Paper 8, at 12-13 (PTAB Oct. 14, 2014) (“In other words, the four obviousness grounds are ‘second bits at the apple,’ which use our prior decision as a roadmap to remedy Butamax’s prior, deficient challenge. Allowing similar, serial challenges to the same patent, by the same petitioner, risks harassment of patent owners and frustration of Congress’s intent in enacting the [AIA].”).  In addition, petitioners may want to have an explanation for why art available at the time of the original petition was omitted. See id. at 12 (“[W]e note that Butamax does not contend that the newly cited references were not known or available to it at the time it filed the 539 IPR.”). However, even not knowing about the art at the time of the earlier petition does not always save petitioners. See, e.g., IPR2013-00324, Paper 19, at 6-7 (PTAB Nov. 21, 2013) (“Furthermore, we note that IBS has not provided any justification for filing the instant petition, other than its representation that it became aware of the relevance of Odedra after the filing of the 128 petition.”).

In sum, if one is considering filing serial petitions attacking the same claims of the same patent, be aware that a look at the numbers reveals a greater risk that at least one petition will be denied than if the petitions were filed in parallel.  In other words, where possible, petitioners may be better off attempting multiple bites at the apple at once by filing their petitions in parallel.

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.

Related Services


Ten Minute Interview: Private Market Investments
07 December 2022
CMS Extends Delayed Enforcement of the Good Faith Estimate
07 December 2022
Health Care Law Today
Tech M&A Outlook: What Types of Deals are Getting Done?
07 December 2022
Foley Ignite
Foley Automotive Report
06 December 2022
Dashboard Insights
What You Should Know About Payor/Provider Convergence
25-26 January 2023
Los Angeles, CA
ATA EDGE2022 Policy Conference | American Telemedicine Association
7-9 December 2022
Washington, D.C.
CLE Weeks
5-16 December 2022
Milwaukee, WI
Foley Sponsors Ernst & Young Entrepreneur of the Year® Program
1 December 2021 - 30 November 2022
Michigan and Northwest Ohio Region